logo
Plus   Neg
Share
Email

JinkoSolar Q2 Profit Surges - Quick Facts

Solar module manufacturer JinkoSolar Holding Co., Ltd. (JKS) reported Wednesday that net income attributable to the company's ordinary shareholders was RMB318.0 million or $45.0 million in the second quarter, sharply higher than RMB125.4 million in the year-ago quarter. Earnings per American depositary share (ADS) were RMB6.55 or $0.93, compared to RMB1.26 last year.

Adjusted net income attributable to the company's ordinary shareholders was RMB376..1 million or $53.2 million, compared to RMB202.9 million last year. Adjusted earnings per ADS were RMB8.46 or $1.20, compared to last year's RMB4.87.

Total revenues for the quarter grew 22.2 percent to RMB8.45 billion or $1.20 billion from RMB6.91 billion last year. Total solar module shipments in the second quarter grew 32.0 percent from last year to 4,469 MW.

Looking ahead to the third quarter, the company expects total solar module shipments to be in the range of 5.0 GW to 5.3 GW. Total revenue for the quarter is expected to be in the range of $1.22 billion to $1.30 billion.

For the full year 2020, the Company still estimates total solar module shipments to be in the range of 18 GW to 20 GW.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Santa Cruz Bicycles LLC has recalled certain model year 2020 bicycles with aluminum frames citing fall risks, according to the U.S. Consumer Product Safety Commission. The recall involves about 2,900 units of model year 2020 Auminum Santa Cruz and Juliana Bicycles. In addition, about 216 were sold in Canada. AstraZeneca is mulling an additional global trial to confirm the 90% efficacy rate of its Covid-19 vaccine candidate at lower dosage, Bloomberg news quoted Chief Executive Officer Pascal Soriot as saying. In an interview, Soriot noted that instead of adding the trial to an ongoing U.S. process, the company might launch a fresh study to evaluate efficacy of lower dosage of its vaccine that perform U.S. airline Delta Air Lines, Inc. and its Italian codeshare partner Alitalia are planning to launch quarantine-free, COVID-free flights between U.S. and Europe through new testing protocols, starting in December. In a statement, Delta said it has signed deals with airports and governments eliminating quarantine requirements on COVID-tested flights connecting Atlanta and Rome.
Follow RTT